Case Report: Recurrent uterine inflammatory myofibroblastic tumor harboring IGFBP5-ALK fusion with sustained response to iruplinalkib

Inflammatory myofibroblastic tumor (IMT) is an extremely rare mesenchymal tumor with approximately 50% of cases harbor anaplastic lymphoma kinase (ALK) gene rearrangements. The tyrosine kinase inhibitor (TKI) treatment has been increasingly common for IMTs with ALK fusions, but evidence for the effi...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Ke Zhao, Min Hu, Runfeng Yang, Yi Huang
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Frontiers Media S.A. 2026-06-01
Reeks:	Frontiers in Oncology
Onderwerpen:	IGFBP5-ALK fusion inflammatory myofibroblastic tumor iruplinalkib tyrosine kinase inhibitor uterine
Online toegang:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1851744/full
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!